¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Benign Essential Tremor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fine tremor
    ¹Ì¼¼¶³¸²
  • flapping tremor
    ÆÛ´ö¶³¸²
  • familial tremor
    °¡Á·¼º¶³¸²
  • hereditary tremor
    À¯Àü¶³¸²
  • intention tremor
    Ȱµ¿¶³¸²
  • intermittent tremor
    °£Çæ¶³¸²
  • kinetic tremor
    Ȱµ¿¶³¸²
  • physiologic tremor
    »ý¸®Àû¶³¸²
  • postural tremor
    üÀ§¶³¸²
  • persistent tremor
    Áö¼Ó¶³¸²
  • rubral tremor
    Àû(»ö)ÇÙ¶³¸²
  • resting tremor
    ¾ÈÁ¤½Ã¶³¸²
  • static tremor
    Á¤Áö½Ã¶³¸²
  • senile tremor
    ³ë³â¶³¸²
  • volitional tremor
    Ȱµ¿¶³¸²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • forced tremor
    °­¹Ú¶³¸²
  • hereditary tremor
    (¢¡essential tremor) º»Å¶³¸², À¯Àü¶³¸², ¿øÀθ𸦶³¸²
  • hysteric tremor
    È÷½ºÅ׸®¶³¸²
  • intention tremor
    (¢¡action tremor) Ȱµ¿¶³¸²
  • intermittent tremor
    °£Çæ¶³¸²
  • kinetic tremor
    (¢¡action tremor) Ȱµ¿¶³¸²
  • persistent tremor
    Áö¼Ó¶³¸²
  • physiologic tremor
    »ý¸®Àû¶³¸²
  • postural tremor
    (¢¡action tremor) Ȱµ¿¶³¸²
  • resting tremor
    ¾ÈÁ¤¶³¸²
  • rubral tremor
    Àû»öÇÙ¶³¸²
  • senile tremor
    ³ëÀμº¶³¸²
  • static tremor
    Á¤Áö½Ã¶³¸²
  • tremor
    ¶³¸²
  • volitional tremor
    (¢¡action tremor) Ȱµ¿¶³¸²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pill rolling tremor
    ȯ¾àÁ¶Á¦¾çÁøÀü(ü¯å·ðàð¥ åÆòèïµ)
  • pill rolling tremor
    ȯ¾àÁ¶Á¦¾çÁøÀü(ü¯å·ðàð¥ åÆòèïµ).
  • postural tremor
    üÀ§¼º ÁøÀü(ô÷êÈàõ òèïµ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°úÇü¼º(¡­Î¦û¡à÷).
  • benign mixed tumor
    ¾ç¼ºÈ¥ÇÕÁ¾, ´ÙÇü¼º¼±Á¾
  • benign mucosal pemphigoid
    ¾ç¼ºÁ¡¸·À¯ÃµÆ÷â
  • benign nephrosclerosis
    ¾ç¼º½Å°æÈ­Áõ(¡­ãìÌãûùñø).
  • benign neurocutaneous melanomatosis
    ¾ç¼º ½Å°æÇÇºÎ Èæ»öÁ¾Áõ
  • benign ovarian tumor
    ¾ç¼º³­¼ÒÁ¾¾ç
  • benign papular acantholytic dermatosis
    ¾ç¼º±¸Áø¼º ±Ø¼¼Æ÷ÇØ¸®ÇǺκ´
  • benign paroxysmal positional vertigo
    ¾ç¼º¹ßÀÛ(¼º)µÎÀ§Çö±â(Áõ)
  • benign paroxysmal positional vertigo
    ¾ç¼º üÀ§¼º µ¹¹ßÇöÈÆ
  • benign partial epilepsy of childhood
    ¼Ò¾Æ±â ¾ç¼ººÎºÐ°£Áú
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³¼±ºñ´ë(Áõ)(¡­îñí¡àÊÝþÓÞñø).
  • benign symmetric lipomatosis
    ¾ç¼º ´ëμºÁö¹æÁ¾Áõ
  • familial benign chronic pemphigus
    °¡Á·¼º ¾ç¼º¸¸¼º õÆ÷â(¡­åÐàõØ·àõô¸øÞóê)
  • hereditary benign intraepithelial dyskeratosis
    À¯Àü¼º ¾ç¼º »óÇdz» ÀÌ»ó°¢È­Áõ
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ET   1) Essential Thrombocytosis
  2) Embryo Transfer
EAA electroacupuncture analgesia; Epilepsy Association of America; essential amino acid; excitatory amin...
EACH essential access community hospital
EFA Epilepsy Foundation of America; essential fatty acid; extrafamily adoptee
EFAD essential fatty acid deficiency
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BFNC Benign Familial Neonatal Convulsions
BIH Benign Intracranial Hypertension
BMG benign monoclonal gammopathy
B.P.P.V. Benign Paroxysmal Positional Vertigo
BPH Benign Prostaic Hyperplasia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tremor
    ÁøÀü, ¶³¸²
    ºÒ¼öÀÇÀûÀÎ ¶³¸²
  • benign aphthae
    ¾ç¼º ¾ÆÇÁŸ
  • benign cementoblastoma
    ¾ç¼º ¹é¾Ç¸ð¼¼Æ÷Á¾, ¾ç¼º ¹é¾Ç¾Æ¼¼Æ÷Á¾
    1. ¸ðµç ¿¬·É¿¡¼­ »ó, ÇÏ, ÁÂ¿ì ¾çÃø¿¡¼­ µ¿½Ã¿¡ ¹ß»ý. Ä¡±Ù ÁÖÀ§¿¡ ¹é¾ÇÁúÀ̳ª ¹é¾ÇÁú¾ç Á¶Á÷ÀÇ µ¢¾î¸®¸¦ Çü¼ºÇÏ´Â ±â´ÉÀû Á¶¹é¾Ç¼¼Æ÷·Î ÀÌ·ç¾îÁø ¾ç¼º Á¾¾çÀÌ´Ù.
  • benign chondroblastoma
    ¾ç¼º ¿¬°ñ¾Æ¼¼Æ÷Á¾
    ¿¬°ñ¾Æ¼¼Æ÷ ¶Ç´Â ±× Àü±¸Ã¼·ÎºÎÅÍ ¹ß»ýµÇ¾î ¿¬°ñ¼¼Æ÷·Î ºÐÈ­µÇ´Â °æÇâÀ» °®´Â ¼¼Æ÷·Î ±¸¼ºµÈ ¾ç¼º Á¾¾çÀÌ´Ù.
  • benign cystic teratoma
    ¾ç¼º ±âÇüÁ¾
  • benign familial pemphigus
    ¾ç¼º °¡Á·¼º õÆ÷â
    µå¹°°Ô ¹ß»ýÇÏ´Â, À¯Àü¼ºÀ̸ç Áö¼ÓÀûÀ¸·Î Àç¹ßÀ» ¹Ýº¹ÇÏ´Â ¼ÒÆ÷¼º ¹× ÀÛÀº ¼öÆ÷¼º ÇǺο°À¸·Î, ¾×¿Í, ¼­ÇýºÎ ¹× ¸ñ ºÎÀ§¸¦ °¡Àå Àß Ä§¹üÇÏÁö¸¸, ¶§·Î´Â ±¤¹üÇÑ ºÎÀ§¸¦ ħ¹üÇÑ´Ù. º´º¯Àº ´Ù¹ß¼ºÀ̸ç, ¼öÁÖÀÏ ³»Áö ¼ö°³¿ù ÈÄ¿¡ ¼èÅðÇÑ´Ù. ÀÌ ÁúȯÀº »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÑ´Ù.
  • benign giant cell tumor
    ¾ç¼º °Å´ë¼¼Æ÷ Á¾¾ç
    1. °ñÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. °ñÀÇ ¾ç¼º Á¾¾çÀÇ Çϳª·Î ³ë¾àÀÚ¿¡°Ô ¸¹À¸¸ç ¹ß»ý ºÎÀ§´Â Àå°ü°ñÀÇ °ñ´Ü¿¡ ¸¹ÀÌ ³ªÅ¸³­´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¿øÇü, ¹æÃßÇüÀÌ ÀÖ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆÄ°ñ¼¼Æ÷¿Í À¯»çÇÑ °Å´ë¼¼Æ÷°¡ È¥ÀçÇÑ´Ù. 2. °ÇÃÊÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. º»·¡ Á¾¾çÀÌ ¾Æ´Ï¸ç, °áÁ¤¼º °ÇÃÊ¿°À» °¡¸®Å°¸ç °ÇÃÊÀÇ ¼¶À¯¼º Á¶Á÷±¸Á¾¿¡ Æ÷ÇԵȴÙ.
  • benign juvenile melanoma
    ¾ç¼º À¯³â¼º Èæ»öÁ¾
    ¾ç¼º, À¶±â¼ºÀÌ¸ç ´Ü´ÜÇϰí ÇÎÅ©»ö ³»Áö ÀÚÀû»öÀ» ¶í ±¸ÁøÀÌ¸ç ´ë°³ ¾à°£ ³«¼³ ¼³Ç¥¸éÀ» °®°í, ÀϹÝÀûÀ¸·Î ¾ó±¼ ƯÈ÷ »´¿¡ ¹ß»ýÇÏ¸ç »çÃá±â Àü¿¡ ¹ßº´ÇÏ´Â °æ¿ì°¡ ¸¹´Ù.
  • benign lymphangioendothelioma
    ¾ç¼º ¸²ÇÁ ³»ÇÇ ¼¼Æ÷Á¾
  • benign lymphoepithelial lesion
    ¾ç¼º ¸²ÇÁ »óÇǼº º´¼Ò
    Ÿ¾×¼±ÀÇ ½ÇÁú Á¶Á÷¿¡ ¸²ÇÁ±¸µéÀÌ Ä§À±µÇ¸é¼­ ¼±¹æ ¼¼Æ÷µéÀÌ ÆÄ±«µÇ°í »óÇDZ٠»óÇǵµ¶ó´Â ƯÀÌÇÑ Á¶Á÷ÇÐÀû ±¸Á¶¹°À» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ» ¸»ÇÑ´Ù. Çö¹Ì°æ ¼Ò°ß¿¡¼­´Â ¿±»ó ±¸Á¶´Â Àß º¸Á¸µÇ¾î ÀÖÀ¸¸é¼­ ¿©Æ÷¸¦ °¡Áø ¸²ÇÁ Á¶Á÷ÀÌ Å¸¾×¼±ÀÇ ½ÇÁú Á¶Á÷À» ´ëÄ¡½Ã۰í, ±ºµ¥±ºµ¥¿¡ »êÀçµÇ¾î ÀÖ´Â »óÇDZ٠»óÇǵµµéÀ» º¼ ¼ö ÀÖ´Ù. ±Ù »óÇÇÀÇ Áõ½ÄÀº Áø´ÜÇÐÀûÀ¸·Î Áß¿äÇϸç ÀÌ·± »óÇDZ٠»óÇǵµ³»¿¡ ÀÖ´Â ÃÊÀÚ¾ç ¹°ÁúÀº ¹Ì¼¼±¸Á¶ÀûÀ¸·Î ±âÀú¸· ¹°Áú·Î µÇ¾î ÀÖ´Ù.
  • benign lymphoid hyperplasia
    ¾ç¼º ¸²ÇÁ °úÇü¼º
  • benign masseteric hypertrophy
    ¾ç¼º ±³±Ù ºñ´ë
    ¿øÀÎ ºÒ¸íÀÇ ÁúȯÀ¸·Î¼­, º¸Åë ¾çÃø¼ºÀ¸·Î ±³±ÙÀÇ Å©±â°¡ ºñ¾Ç¼ºÀ¸·Î Áõ°¡ÇÑ´Ù.
  • benign melanocytic tumor
    ¾ç¼º ¸á¶ó´Ñ ¼¼Æ÷Á¾
  • benign migratory glossitis
    ¾ç¼º À̵¿¼º ¼³¿°, ¾ç¼º ÀÌÁÖ¼º ¼³¿°, ¾ç¼º ÀüÀ̼º ¼³¿°
    1. ¸ð»óÀ¯µÎ°¡ ¼Ò½ÇµÇ°í º´¼ÒÀÇ º¯¿¬ÀÌ °ú°¢È­µÇ¸ç, »óÇÇÃþ¿¡ ÀÛÀº ³ó¾çÀÌ º¸ÀδÙ. °íÀ¯ÆÇ¿¡µµ ¿°Áõ ¼¼Æ÷°¡ ħÀ±ÇÑ´Ù. ¹«Å뼺À̳ª ¶§·Î´Â µ¿ÅëÀ» º¸À̰í Àڱؿ¡ ¹Î°¨ÇÏ°Ô ¹ÝÀÀÇÑ´Ù. 2. ¼³¸éÀÇ Áöµµ»óÀÇ Àû»ö ¹ÝÁ¡ÀÇ À̵¿ÀÌ ÀÖ´Ù. ¿©¼º¿¡ È£¹ßÇÑ´Ù.
  • benign mucous membrane pemphigoid
    ¾ç¼º Á¡¸· À¯ÃµÆ÷â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
essential gene <genetics> Any gene that, if it does not workcorrectly, kills the organism.
(09 Oct 1997)
essential hypertension Hypertension without known cause.
Synonym: idiopathic hypertension, primary hypertension.
(05 Mar 2000)
essential oils Plant products, usually somewhat volatile, giving the odours and tastes characteristic of the particular plant, thus possessing the essence, e.g., citral, pinene, camphor, menthane, terpenes; usually, the steam distillates of plants or oils of plants obtained by pressing out the rinds of a particular plant.
See: volatile oil.
(05 Mar 2000)
essential phthisis bulbi A softening of the eyeball (ophthalmomalacia) and reduction in size, not due to inflammation.
(05 Mar 2000)
essential progressive atrophy of iris Progressive atrophy of the iris without inflammatory signs, characterised by patchy loss of all layers of the iris with hole formation, migration of the pupil, degeneration of the corneal endothelium, peripheral anterior synechiae, and secondary glaucoma; usually unilateral, predominantly affecting women in their middle years.
(05 Mar 2000)
essential pruritus Itching that occurs independently of skin lesions.
(05 Mar 2000)
essential tachycardia Persistent rapid action of the heart due to no discoverable organic lesion.
(05 Mar 2000)
essential telangiectasia Localised capillary dilation of undetermined origin.
Synonym: angioma serpiginosum.
(05 Mar 2000)
essential thrombocythaemia A rare condition related to polycythaemia rubra vera characterised by the production of large numbers of abnormal platelets.
Symptoms include haemorrhage, blood clots and enlargement of the spleen. Treatment varies according to the severity of the disease.
(13 Nov 1997)
essential thrombocytopenia A primary form of thrombocytopenia, in contrast to secondary forms that are associated with metastatic neoplasms, tuberculosis, and leukaemia involving the bone marrow, or with direct suppression of bone marrow by the use of chemical agents, or with other conditions.
(05 Mar 2000)
fatty acids, essential Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids.
(12 Dec 1998)
action tremor <neurology> A tremor which arises or which is intensified when a voluntary, coordinated movement is attempted.
(18 Nov 1997)
alcoholic withdrawal tremor Intention tremor present in the withdrawal period of one of two types: 1) a tremor of greater than 8 Hz, with continuous antagonistic muscle activity, and 2) a tremor of less than 8 Hz, with intermittent spontaneous antagonistic muscle activity.
(05 Mar 2000)
alternating tremor A form of hyperkinesia characterised by regular, symmetrical, to-and-fro movements (at about 4 per second) that are produced by patterned, alternating contraction of muscles and their antagonists.
(05 Mar 2000)
alternative tremor A coarse, low frequency (3-8 Hz) pathologic tremor produced by alternating contraction of muscles and their antagonists; seen with Parkinson disease and kinetic predominant action tremor.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á